Physician profile
Sadiq Lafta Altamimi
NPI 1639381619
$29,933.38
in general payments reported to CMS, 2019-2025
80 companies · $7,607 in 2025
The $7,607 reported for 2025 was more than what 87% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,180 · 2020: $1,255 · 2021: $1,910 · 2022: $4,269 · 2023: $5,352 · 2024: $5,361 · 2025: $7,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $63.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,256.50 |
| Education | $63.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,170.08 | 2019-2025 | Botox, Qulipta, Ubrelvy |
| Ucb, INC. | $2,985.97 | 2019-2025 | Rystiggo, Fintepla, Briviact |
| Alexion Pharmaceuticals, INC. | $1,957.85 | 2019-2025 | Ultomiris, Soliris |
| Biogen, INC. | $1,738.00 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Novartis Pharmaceuticals Corporation | $1,558.88 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $1,497.57 | 2019-2025 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $1,090.67 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Pfizer INC. | $1,071.50 | 2023-2025 | |
| Lilly USA, LLC | $966.36 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Argenx US, INC. | $912.69 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amneal Pharmaceuticals LLC | $907.85 | 2019-2025 | Rytary, Crexont |
| Octapharma USA, INC. | $898.62 | 2022-2025 | Panzyga |
| Allergan, INC. | $700.16 | 2019-2022 | |
| Amgen INC. | $589.58 | 2019-2025 | Uplizna |
| Lundbeck LLC | $568.34 | 2023-2025 | Vyepti, Rexulti |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $506.17 | 2019-2022 | |
| Emd Serono, INC. | $464.85 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $459.93 | 2023-2025 | Rexulti, Nuedexta |
| Sk Life Science, INC. | $430.05 | 2021-2025 | Xcopri |
| Mdd US Operations, LLC | $426.30 | 2019-2025 | Gocovri, Apokyn |
| Alnylam Pharmaceuticals INC. | $321.02 | 2019-2025 | Amvuttra, Onpattro |
| Avanir Pharmaceuticals, INC. | $319.90 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $313.09 | 2021-2025 | Hyqvia, Gammagard |
| Eisai INC. | $297.34 | 2019-2025 | |
| Livanova USA, INC. | $268.62 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurocrine Biosciences, INC. | $261.26 | 2019-2025 | Ingrezza, Ongentys |
| Celgene Corporation | $248.55 | 2024-2025 | Zeposia |
| Acorda Therapeutics, INC | $232.69 | 2019-2020 | |
| Axsome Therapeutics, INC. | $223.87 | 2025 | Symbravo |
| Supernus Pharmaceuticals, INC. | $215.51 | 2019-2023 | Qelbree |
| Csl Behring | $199.78 | 2019-2022 | |
| Greenwich Biosciences, INC. | $191.35 | 2019-2021 | |
| Tanabe Pharma America, INC. | $181.44 | 2019-2025 | Radicava |
| Genentech USA, INC. | $172.88 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Forte Bio-Pharma LLC | $166.37 | 2025 | Tanlor |
| Akcea Therapeutics, INC. | $139.48 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $138.58 | 2020-2021 | |
| Genzyme Corporation | $118.68 | 2020-2025 | |
| Jazz Pharmaceuticals INC. | $118.05 | 2022-2025 | |
| Merz Pharmaceuticals, LLC | $117.20 | 2023-2025 | Xeomin, Inbrija |
| Catalyst Pharmaceuticals, INC. | $109.76 | 2021-2025 | Firdapse |
| Abbott Laboratories | $106.87 | 2019-2025 | Infinity |
| Avion Pharmaceuticals | $98.95 | 2022-2023 | Dhivy |
| Kyowa Kirin, INC. | $97.75 | 2019-2024 | Nourianz |
| Boston Scientific Corporation | $91.34 | 2021-2025 | Superion Indirect Decompression System, General - Pain Management, Wavewriter Alpha Prime 16 |
| Janssen Biotech, INC. | $83.66 | 2025 | |
| Terumo Bct, INC. | $79.55 | 2022 | |
| Grifols USA, LLC | $77.63 | 2019-2025 | Gamunex-C |
| Ge Healthcare | $74.21 | 2020-2025 | |
| Corium, LLC | $68.21 | 2022-2023 | Adlarity |
| Adamas Pharmaceuticals, INC. | $62.27 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $57.55 | 2023-2024 | Ztlido |
| Portola Pharmaceuticals, LLC | $56.31 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $52.06 | 2023 | Dysport |
| Microtransponder, INC. | $50.87 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $49.92 | 2025 | Wainua |
| Mallinckrodt Enterprises LLC | $47.98 | 2019 | |
| Xeris Pharmaceuticals, INC. | $40.71 | 2021-2023 | Keveyis |
| Aucta Pharmaceuticals, INC. | $38.70 | 2024-2025 | Motpoly Xr |
| Arbor Pharmaceuticals, INC. | $36.51 | 2022 | |
| Averitas Pharma INC. | $33.17 | 2025 | Qutenza |
| Neurelis, INC. | $32.77 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $30.79 | 2022 | |
| Neuropace, INC. | $29.20 | 2025 | |
| Sumitomo Pharma America, INC. | $28.30 | 2023 | Aptiom |
| Vanda Pharmaceuticals INC. | $28.26 | 2025 | Ponvory |
| Sanofi-Aventis U.S. LLC | $22.47 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.70 | 2024 | Acthar |
| Tonix Medicines, INC. | $18.61 | 2025 | Zembrace Symtouch |
| Amylyx Pharmaceuticals, INC. | $17.95 | 2023 | Relyvrio |
| E.R. Squibb & Sons, L.L.C. | $16.77 | 2021 | |
| Cala Health, INC. | $15.69 | 2023 | Cala Trio |
| Vertical Pharmaceuticals, LLC | $15.42 | 2019 | |
| Azurity Pharmaceuticals, INC. | $15.10 | 2023 | Horizant |
| Assertio Therapeutics, INC. | $14.84 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.28 | 2022 | |
| Upsher-Smith Laboratories LLC | $13.66 | 2020 | |
| W. L. Gore & Associates, INC. | $12.61 | 2020 | |
| Zogenix INC. | $12.60 | 2021 | |
| Zyla Life Sciences, INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
Botox $1,990Qulipta $1,684Rystiggo $1,154Ubrelvy $1,151Nuplazid $1,106Kesimpta $1,014Ultomiris $862Nurtec Odt $779Vumerity $725Zavzpret $688Leqembi $628Austedo Xr $620Vyvgart Hytrulo $572Tysabri $449Fintepla $433Vyepti $432Rytary $370Rexulti $369Panzyga $358Crexont $288Octagam Immune Globulin (Human) $287Uplizna $276Zeposia $249Nuedexta $227Symbravo $224Vyvgart $223Briviact $191Tanlor $166Nayzilam $149Kisunla $145Amyvid $138Emgality $136Gocovri $136Ingrezza $115Radicava $113Ocrevus $103Austedo $98.03Radicava Ors $95.52Amvuttra $83.68Xywav $83.01Hyqvia $80.94Ongentys $76.92Xeomin $74.57Vns Therapy Sentiva Model 1000 Generator $72.20Firdapse $72.02Gamunex-C $65.27Ztlido $57.55Dhivy $56.66Nourianz $54.27Dysport $52.06Wainua $49.92Infinity $49.38Exservan $49.09Zilbrysq $47.81Onpattro $47.69Ocrevus Zunovo $47.26Inbrija $42.63Motpoly Xr $38.70Superion Indirect Decompression System $37.22Qutenza $33.17Qelbree $32.55Soliris $31.69Fabrazyme $29.38Rns Neurostimulator Kit $29.20Aptiom $28.30Ponvory $28.26Avonex $27.18Adlarity $26.20General - Pain Management $26.02Apokyn $25.39Paxlovid $23.20Comirnaty $23.20Acthar $21.70Keveyis $21.03Zembrace Symtouch $18.61Relyvrio $17.95Gammagard $17.61Cala Trio $15.69Horizant $15.10Agamree $14.71Skyclarys $13.37Wavewriter Alpha Prime 16 $13.00Xcopri $7.00
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadiq Altamimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.